Intel is falling further behind Taiwan Semiconductor Manufacturing in computer chips. The company is hemorrhaging cash and seeing little progress with its new manufacturing plans.
Intel's foundry business has struggled, with a recent rejection by Broadcom the latest blow to the unit. Intel's woes are TSMC's gains, as it should help eliminate potential capacity increases at its rival.
Intel's stock remains significantly overvalued despite a 37% drop since mid-June, with a "Strong Sell" rating due to inefficiencies and poor strategic decisions. Recent quarterly earnings missed estimates, with revenue down 1% YoY and adjusted EPS dropping to $0.02, highlighting financial struggles. Intel's balance sheet is weaker than rivals like Nvidia and AMD, with high debt and lower profitability, making it less competitive.
Mobileye Global Inc.'s stock has plummeted due to poor performance, and the Lidar development news isn't necessarily helpful. Intel's rumored share sale is a major overhang, with the chip giant needing cash amid struggles in its foundry business and AI market miss. Mobileye Global stock is fairly valued at 5x forward sales, but significant improvement in business performance is needed before considering it a Buy.
Zacks.com users have recently been watching Intel (INTC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Key Points: Intel is considering breaking up amid struggles and declining market position.
Intel's Arrow Lake PC CPUs will now be outsourced as Intel shifts resources from the Intel 20A process. The company expects to save around $500 million in capital spending by killing off the commercialization of Intel 20A.
Intel's ambitious 2026 targets have not been met, leading to significant investor angst and the sharpest decline in its stock price seen since 1975. Management is actively working to restore investor confidence through cost-cutting measures, potential asset sales, and streamlining the business portfolio. The company's stock is undervalued, trading below its book value, despite the company's strategic importance and ongoing cost reduction initiatives.
Intel's stock dropped over 18% due to poor profitability, workforce reduction, dividend suspension, and lower guidance, creating a negative outlook. Despite challenges, Intel is investing in AI and foundry segments, with new product releases like the Gaudi 3 AI accelerator expected in Q3 2024. Operating margins and revenue forecasts have been lowered, but long-term investments and cost-cutting measures aim to stabilize future profitability.
INTC collaborates with TrueBusiness to introduce revolutionary smart healthcare solutions in Southeast Asia.
Intel is in a cash crunch and could sell pieces of its business to raise capital.
Intel NASDAQ: INTC has had a terrible 2024, to say the least. The company's shares are down 61% year-to-date, driven largely by a massive earnings miss in August.